$474 Million is the total value of RTW INVESTMENTS, LP's 28 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 35.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PTCT | Buy | PTC Therapeutics Inc | $60,566,000 | +371.4% | 3,304,214 | +153.1% | 12.77% | +277.5% |
| BMY | Buy | Bristol-Myers Squibb Co | $43,165,000 | +39.1% | 774,675 | +35.7% | 9.10% | +11.4% |
| LJPC | Buy | La Jolla Pharmaceutical Co | $32,967,000 | +7.3% | 1,107,379 | +7.6% | 6.95% | -14.0% |
| RGNX | Buy | Regenxbio Inc | $25,137,000 | +7.1% | 1,272,770 | +4.6% | 5.30% | -14.3% |
| ABUS | Buy | Arbutus Biopharma Corp | $18,755,000 | +299.0% | 5,209,823 | +260.1% | 3.95% | +219.6% |
| AGEN | Buy | Agenus Inc | $16,725,000 | +4.5% | 4,277,456 | +0.7% | 3.53% | -16.3% |
| ATRA | Buy | Atara Biotherapeutics Inc | $16,418,000 | -12.1% | 1,172,744 | +29.1% | 3.46% | -29.6% |
| OXFD | Buy | Oxford Immunotec Global PLC | $14,245,000 | +50.0% | 846,917 | +38.2% | 3.00% | +20.2% |
| CORI | Buy | Corium International Inc | $12,175,000 | +101.0% | 1,632,001 | +12.6% | 2.57% | +61.0% |
| BLUE | Buy | bluebird bio Inc | $10,965,000 | +16.4% | 104,383 | +0.7% | 2.31% | -6.8% |
| TCMD | Buy | Tactile Systems Technology Inc | $10,640,000 | +95.1% | 372,302 | +29.3% | 2.24% | +56.2% |
| OSUR | Buy | OraSure Technologies Inc | $10,153,000 | +38.7% | 588,256 | +3.9% | 2.14% | +11.1% |
| MASI | Buy | Masimo Corp | $9,200,000 | +21.9% | 100,900 | +24.7% | 1.94% | -2.4% |
| VIVE | Buy | Viveve Medical Inc | $8,899,000 | +22.7% | 1,239,443 | +8.2% | 1.88% | -1.7% |
| ACHN | New | Achillion Pharmaceuticals Inc | $7,300,000 | – | 1,590,454 | +100.0% | 1.54% | – |
| DRNA | Buy | Dicerna Pharmaceuticals Inc | $6,590,000 | -6.0% | 2,078,991 | +0.8% | 1.39% | -24.8% |
| VRAY | Buy | Viewray Inc | $4,945,000 | +12.7% | 764,335 | +48.2% | 1.04% | -9.8% |
| OMER | New | Omeros Corp | $4,727,000 | – | 237,453 | +100.0% | 1.00% | – |
| SBPH | New | Spring Bank Pharmaceuticals Inc | $3,385,000 | – | 250,000 | +100.0% | 0.71% | – |
| UHS | New | Universal Health Services Inccl b | $3,150,000 | – | 25,800 | +100.0% | 0.66% | – |
| PODD | New | Insulet Corp | $2,976,000 | – | 58,000 | +100.0% | 0.63% | – |
| GBT | Buy | Global Blood Therapeutics Inc | $721,000 | -25.3% | 26,377 | +0.7% | 0.15% | -40.2% |
| ARGX | New | Argenx Nvsponsored adr | $530,000 | – | 24,970 | +100.0% | 0.11% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS INC | 36 | Q3 2023 | 19.7% |
| MASIMO CORP | 32 | Q3 2023 | 5.8% |
| LA JOLLA PHARMACEUTICAL CO | 31 | Q2 2022 | 9.7% |
| REGENXBIO INC | 30 | Q4 2022 | 10.8% |
| AGENUS INC | 29 | Q2 2022 | 9.0% |
| PTC THERAPEUTICS INC | 28 | Q3 2023 | 12.8% |
| DICERNA PHARMACEUTICALS INC | 28 | Q3 2021 | 10.8% |
| MIRATI THERAPEUTICS INC | 26 | Q3 2023 | 6.2% |
| ARGENX SE | 26 | Q3 2023 | 5.3% |
| VERICEL CORP | 24 | Q3 2023 | 3.9% |
View RTW INVESTMENTS, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | September 19, 2023 | 18,188,457 | - |
| ALLURION TECHNOLOGIES, INC. | August 11, 2023 | 3,457,707 | 7.4% |
| Orchestra BioMed Holdings, Inc. | May 05, 2023 | 5,620,645 | 15.7% |
| Renovacor, Inc.Sold out | April 05, 2023 | 0 | - |
| Adverum Biotechnologies, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Aptevo Therapeutics Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ASLAN Pharmaceuticals LtdSold out | February 14, 2023 | 0 | 0.0% |
| Athira Pharma, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| BELLUS Health Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Clearside Biomedical, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
View RTW INVESTMENTS, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-03-01 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View RTW INVESTMENTS, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.